Jim Simons's position in Beam Therapeutics is currently worth $4.01 Million. That's 0.01% of their equity portfolio (1601st largest holding). The first Beam Therapeutics trade was made in Q1 2021. Since then Jim Simons bought shares two more times and sold shares on three occasions. The investor's estimated purchase price is $5.36 Million, resulting in a loss of 25%.